News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Harvard Apparatus (HART) Regenerative Technology Posts Updated Investor Presentation On Its Website


3/14/2014 7:07:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, has posted an updated version of its investor presentation on its website.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES